Currently out of the existing stock ratings of Joori Park, 3 are a BUY (100%).
Analyst Joori Park, currently employed at LEERINK,
Joori Park has documented 5 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on LRMR, Larimar Therapeutics at 29-Sep-2025.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Oct-2024
$9
$5.86 (186.62%)
$11
5 days ago
(17-Nov-2026)
Buy Since 20-Mar-2015
$13
$9.86 (314.01%)
$132
2 months 8 days ago
(14-Sep-2026)
1/5 (20%)
$9.22 (243.92%)
1022
Buy Since 10-Feb-2021
$18
$14.86 (473.25%)
$18
4 months 15 days ago
(07-Jul-2026)
0/16 (0%)
$14.59 (427.86%)
Buy Since 03-Sep-2024
$5
$1.86 (59.24%)
$7
4 months 23 days ago
(30-Jun-2026)
0/5 (0%)
$1.95 (63.93%)
Buy Since 13-Feb-2024
$14
$10.86 (345.86%)
8 months 28 days ago
(25-Feb-2026)
3/7 (42.86%)
$8.05 (135.29%)
88
What Year was the first public recommendation made by Joori Park?